COMMUNIQUÉS West-GlobeNewswire

Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET™ Needle-Free Delivery System

30/05/2018 - 13:00

EWING, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (“Antares”) (“The Company”) today announced that it has received $4.75 million from Ferring Pharmaceuticals (“Ferring”) in connection [...]

ContraFect to Present New Data on CF-301 (exebacase) and Lysins Targeting Gram-Negative Pathogens at ASM Microbe 2018

30/05/2018 - 13:00

YONKERS, N.Y., May 30, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX ), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]

International Stem Cell Corporation Published Technology for Cartilage Generation in Journal of Tissue Engineering and Regenerative Medicine Technology

30/05/2018 - 13:00

CARLSBAD, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]

Microbot Medical Inc. Schedules its Periodical Townhall Meeting for Monday, June 4th at 9:00 a.m., Eastern Time

30/05/2018 - 13:00

HINGHAM, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

AnaptysBio to Present at the Jefferies 2018 Global Healthcare Conference

30/05/2018 - 12:30

SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, [...]

Avivagen Announces Approval of OxC-beta™ For Use in Livestock in New Zealand

30/05/2018 - 12:30

OTTAWA, May 30, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]

iKang Schedules 2017 Unaudited Fourth Quarter and Fiscal Year Earnings Release on June 21, 2018

30/05/2018 - 12:05

BEIJING, May 30, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), major provider in China’s fast growing private preventive healthcare services market, today announced [...]

OraSure Technologies to Present at Jefferies Global Healthcare Conference

30/05/2018 - 12:00

BETHLEHEM, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President [...]

Affimed to Present at the Jefferies Global Healthcare Conference

30/05/2018 - 11:00

Heidelberg, Germany, May 30, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]

Wake Radiology Launches EnvoyAI Platform in First-of-Kind Implementation

30/05/2018 - 11:00

RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- Artificial intelligence platform provider, EnvoyAI TM ( www.envoyai.com ), recently completed their first successful customer installation at Wake Radiology ( www.wakerad. [...]

Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid Leukemia (AML) in adult patients unfit f

30/05/2018 - 09:00

Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid Leukemia (AML) in [...]

Herantis Pharma's Manager's Transactions

30/05/2018 - 08:31

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 30 May 2018 at 9:30 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Shire plc : Rule 2.9 Announcement

30/05/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 May 2018 Shire [...]

ERYTECH to Webcast Presentation at the Jefferies Global Healthcare Conference

30/05/2018 - 07:30

LYON, France, May 30, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]

FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)

30/05/2018 - 07:16

Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (IST) Regulatory [...]

Navamedic ASA: Q1 2018 results

30/05/2018 - 07:01

Oslo, May 30, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 42.6 million in the first quarter of 2018, down from NOK 78.2 million in the same period in 2017, following the planned discontinuation of the [...]

INNATE PHARMA : Outcome of Annual General Meeting of May 29, 2018

30/05/2018 - 07:01

OUTCOME of ANNUAL GENERAL MEETING OF MAY 29, 2018 Marseille, France, May 30, 2018, 7:00 AM CEST Innate Pharma (Euronext Paris: FR0010331421 - IPH) announces the results of the voting by shareholders at the Annual [...]

INNATE PHARMA : Résultats de l'Assemblée Générale mixte du 29 mai 2018

30/05/2018 - 07:01

RÉSULTATS DE L'ASSEMBLÉE GÉNÉRALE MIXTE DU 29 MAI 2018 Marseille, le 30 mai 2018, 7h00 CEST Innate Pharma SA (Euronext Paris : FR0010331421 - IPH) annonce les résultats du vote des actionnaires à l'Assemblée générale [...]

Amicus Therapeutics Launches Galafold® (Migalastat) for Fabry Disease in Japan

30/05/2018 - 06:00

First Oral Precision Medicine for Fabry Patients with an Amenable Mutation Now Available in Japan CRANBURY, N.J. and TOKYO, May 30, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) has initiated the [...]